19 research outputs found
Stringy effects in black hole decay
We compute the low energy decay rates of near-extremal three(four) charge
black holes in five(four) dimensional N=4 string theory to sub-leading order in
the large charge approximation. This involves studying stringy corrections to
scattering amplitudes of a scalar field off a black hole. We adapt and use
recently developed techniques to compute such amplitudes as near-horizon
quantities. We then compare this with the corresponding calculation in the
microscopic configuration carrying the same charges as the black hole. We find
perfect agreement between the microscopic and macroscopic calculations; in the
cases we study, the zero energy limit of the scattering cross section is equal
to four times the Wald entropy of the black hole.Comment: 32 page
New Noncovalent Inhibitors of Penicillin-Binding Proteins from Penicillin-Resistant Bacteria
BACKGROUND: Penicillin-binding proteins (PBPs) are well known and validated targets for antibacterial therapy. The most important clinically used inhibitors of PBPs beta-lactams inhibit transpeptidase activity of PBPs by forming a covalent penicilloyl-enzyme complex that blocks the normal transpeptidation reaction; this finally results in bacterial death. In some resistant bacteria the resistance is acquired by active-site distortion of PBPs, which lowers their acylation efficiency for beta-lactams. To address this problem we focused our attention to discovery of novel noncovalent inhibitors of PBPs. METHODOLOGY/PRINCIPAL FINDINGS: Our in-house bank of compounds was screened for inhibition of three PBPs from resistant bacteria: PBP2a from Methicillin-resistant Staphylococcus aureus (MRSA), PBP2x from Streptococcus pneumoniae strain 5204, and PBP5fm from Enterococcus faecium strain D63r. Initial hit inhibitor obtained by screening was then used as a starting point for computational similarity searching for structurally related compounds and several new noncovalent inhibitors were discovered. Two compounds had promising inhibitory activities of both PBP2a and PBP2x 5204, and good in-vitro antibacterial activities against a panel of Gram-positive bacterial strains. CONCLUSIONS: We found new noncovalent inhibitors of PBPs which represent important starting points for development of more potent inhibitors of PBPs that can target penicillin-resistant bacteria.Eur-Intafa